TXMD Earnings
Latest Revenue869.0K
Latest Net Income155.0K
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $0.01 | 869.0K | 155.0K | -8.7% | -80.0% |
| Q1 2026 | $0.01 | 724.0K | 95.0K | +84.2% | +116.7% |
| Q4 2025 | -$0.05 | 893.0K | -619000 | +33.9% | -350.0% |
| Q3 2025 | $0.01 | 784.0K | 152.0K | +43.3% | +120.0% |
| Q2 2025 | $0.05 | 952.0K | 551.0K | +306.8% | +155.6% |
| Q1 2025 | -$0.06 | 393.0K | -653000 | +25.6% | +0.0% |
| Q4 2024 | $0.02 | 667.0K | 252.0K | +32.9% | +125.0% |
| Q3 2024 | -$0.05 | 547.0K | -609000 | +1,132.1% | +84.4% |
| Q2 2024 | -$0.09 | 234.0K | -1090000 | — | — |
| Q1 2024 | -$0.06 | 313.0K | -734000 | — | — |
| Q4 2023 | -$0.08 | 502.0K | -883000 | — | — |
| Q3 2023 | -$0.32 | -53000 | -3378000 | — | — |
TherapeuticsMD (TXMD) — Earnings